Terman B I, Reece J F, Brown R D, Insel P A
Department of Pharmacology, University of California, San Diego, La Jolla 92093.
Biochem J. 1988 Jul 15;253(2):363-70. doi: 10.1042/bj2530363.
In this study, we clarify the structural aspects of the oligosaccharides associated with the alpha 1-adrenergic receptor in two muscle cell lines. Photoaffinity labelling of intact BC3H1 or DDT1 muscle cells with 2-[4-(4-azido-3-[125I]iodobenzoyl)piperazin-1-yl]-4-amino-6, 7-dimethoxyquinazoline ([125I]azidoprazosin) followed by SDS/polyacrylamide-gel electrophoresis (PAGE) and autoradiography revealed specifically labelled proteins of molecular mass = 87,000 and 81,000, respectively. Treatment of photoaffinity-labelled receptors in DDT1 cells with 33 u. of endoglycosidase F/ml for 24 h resulted in the loss of the 81 kDa receptor and the appearance of a 52.5 kDa protein. When lower concentrations of glycosidase or shorter incubation times were used, the 81 kDa receptor was converted to a 66 kDa protein. Treatment of the photoaffinity-labelled BC3H1 receptor with endoglycosidase F resulted in the appearance of a 50.5 kDa protein. Neither alpha-mannosidase nor endoglycosidase H had an effect on the photoaffinity labelling patterns of the receptor from the two cell types. alpha 1-Adrenergic receptors, solubilized from membranes prepared from BC3H1 and DDT1 cells, bound to wheat germ agglutinin-Sepharose and were displaced by N-acetylglucosamine. Taken together, these results indicate that alpha 1-adrenergic receptors in BC3H1 and DDT1 cells contain complex, but not high, mannose oligosaccharide chains; differences in the composition or number of chains partially accounts for the different molecular mass of the receptor in the two cell lines. The results further indicate that the oligosaccharide chains contribute substantially to the apparent molecular mass of alpha 1-adrenergic receptors, as detected by SDS/PAGE, and that the protein backbone of these receptors is likely to be approximately 50 kDa.
在本研究中,我们阐明了两种肌肉细胞系中与α1 - 肾上腺素能受体相关的寡糖的结构方面。用2 - [4 - (4 - 叠氮基 - 3 - [125I]碘苯甲酰基)哌嗪 - 1 - 基] - 4 - 氨基 - 6,7 - 二甲氧基喹唑啉([125I]叠氮哌唑嗪)对完整的BC3H1或DDT1肌肉细胞进行光亲和标记,然后进行SDS/聚丙烯酰胺凝胶电泳(PAGE)和放射自显影,分别显示出分子量为87,000和81,000的特异性标记蛋白。用33单位/毫升的内切糖苷酶F处理DDT1细胞中经光亲和标记的受体24小时,导致81 kDa受体消失,出现一个52.5 kDa的蛋白。当使用较低浓度的糖苷酶或较短的孵育时间时,81 kDa受体转变为一个66 kDa的蛋白。用内切糖苷酶F处理经光亲和标记的BC3H1受体,出现一个50.5 kDa的蛋白。α - 甘露糖苷酶和内切糖苷酶H对这两种细胞类型受体的光亲和标记模式均无影响。从BC3H1和DDT1细胞制备的膜中溶解的α1 - 肾上腺素能受体与麦胚凝集素 - 琼脂糖结合,并被N - 乙酰葡糖胺取代。综上所述,这些结果表明BC3H1和DDT1细胞中的α1 - 肾上腺素能受体含有复杂但并非高甘露糖型的寡糖链;链的组成或数量差异部分解释了两种细胞系中受体分子量的不同。结果还进一步表明,寡糖链对SDS/PAGE检测到的α1 - 肾上腺素能受体的表观分子量有很大贡献,并且这些受体的蛋白质主链可能约为50 kDa。